Get the Stockscreener App
101.96
1.47%
1.48
After Hours:
101.95
-0.010
-0.01%
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp stock is traded at $101.96, with a volume of 11.18M.
It is up +1.47% in the last 24 hours and up +7.16% over the past month.
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
See More
Previous Close:
$100.48
Open:
$100.89
24h Volume:
11.18M
Relative Volume:
1.39
Market Cap:
$130.09B
Revenue:
$407.94B
Net Income/Loss:
$2.90B
P/E Ratio:
44.78
EPS:
2.2771
Net Cash Flow:
$7.39B
1W Performance:
+6.29%
1M Performance:
+7.16%
6M Performance:
+28.38%
1Y Performance:
+53.67%
1-Day Range:
$100.01
$102.77
1-Week Range:
$94.89
$102.77
52-Week Range:
$58.50
$102.77
Cvs Health Corp Stock (CVS) Company Profile
Name
Cvs Health Corp
Sector
Industry
Phone
(401) 765-1500
Address
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
101.96 | 130.09B | 407.94B | 2.90B | 7.39B | 2.2771 |
UNH
Unitedhealth Group Inc
|
408.52 | 371.00B | 449.71B | 12.81B | 19.67B | 13.24 |
ELV
Elevance Health Inc
|
404.07 | 87.75B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
298.00 | 78.83B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
379.22 | 45.53B | 137.20B | 1.15B | 1.27B | 9.3439 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-26 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-14-25 | Initiated | Goldman | Buy |
| Aug-18-25 | Upgrade | UBS | Neutral → Buy |
| Aug-14-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-13-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Feb-12-25 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Jan-30-25 | Upgrade | Edward Jones | Hold → Buy |
| Dec-03-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Nov-18-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-10-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Oct-04-24 | Upgrade | TD Cowen | Hold → Buy |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| May-07-24 | Downgrade | TD Cowen | Buy → Hold |
| May-02-24 | Downgrade | UBS | Buy → Neutral |
| May-01-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-01-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Dec-22-23 | Initiated | HSBC Securities | Buy |
| Sep-19-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Sep-12-23 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| May-26-23 | Initiated | Piper Sandler | Overweight |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-29-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Feb-11-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Dec-01-21 | Initiated | Seaport Research Partners | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Mar-17-21 | Downgrade | Guggenheim | Buy → Neutral |
| Jan-08-21 | Upgrade | Jefferies | Hold → Buy |
| Sep-17-20 | Initiated | Piper Sandler | Overweight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Sep-27-19 | Resumed | RBC Capital Mkts | Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jun-05-19 | Upgrade | Standpoint Research | Hold → Buy |
| Apr-29-19 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Apr-15-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-10-19 | Reiterated | BofA/Merrill | Buy |
| Mar-13-19 | Initiated | Bernstein | Outperform |
| Feb-20-19 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Jan-17-19 | Initiated | UBS | Buy |
| Dec-18-18 | Initiated | Barclays | Overweight |
| Nov-29-18 | Resumed | Goldman | Neutral |
| Nov-28-18 | Initiated | Evercore ISI | Outperform |
| Oct-26-18 | Resumed | Wolfe Research | Peer Perform |
| Jul-09-18 | Upgrade | Citigroup | Neutral → Buy |
| Feb-27-18 | Resumed | BofA/Merrill | Buy |
| Feb-13-18 | Reiterated | Citigroup | Neutral |
View All
Cvs Health Corp Stock (CVS) Latest News
CVS Health Corp. Stock (US1266501006): Valuation Back In Focus After Recent Rebound - AD HOC NEWS
Why Is CVS Health Stock Trending Right Now - Kalkine Media
State Street Corp Acquires 1,245,457 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Acquired by Rhenman & Partners Asset Management AB - MarketBeat
Macquarie Group Ltd. Lowers Stock Position in CVS Health Corporation $CVS - MarketBeat
CVS Health (NYSE:CVS) Stock Rating Lowered by Wall Street Zen - MarketBeat
CVS Health Corp. stock outperforms competitors on strong trading day - MarketWatch
CVS Pharmacy mobile app: health, refills and rewards in one place - AD HOC NEWS
CVS, Humana, and UnitedHealth Face Medicare Advantage Approval C - GuruFocus
CVS Health (CVS): Buy, Sell, or Hold Post Q1 Earnings? - Yahoo Finance UK
Is CVS (CVS) Using GLP-1 Access and AI Tools to Redefine Its Healthcare Moat? - Yahoo Finance
Danaher Boosts Product Portfolio With the Acquisition of Masimo - TradingView
CVS Health Corp (CVS) Stock Price, Trades & News - GuruFocus
CVS Health expands Salesforce partnership for AI call centers - Investing.com
CVS Health expands Salesforce partnership for AI call centers By Investing.com - Investing.com Canada
CVS Health Corporation (CVS) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
CVS Health To Deliver Faster, More Personalized Call Center Care for Millions of Members With Salesforce's Agentforce Health - StreetInsider
Sector Gamma AS Buys 21,397 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Te Ahumairangi Investment Management Ltd - MarketBeat
Great Lakes Advisors LLC Trims Position in CVS Health Corporation $CVS - MarketBeat
Cutler Investment Counsel LLC Buys 20,825 Shares of CVS Health Corporation $CVS - MarketBeat
CNO Financial Group Stock (US1266501006): Valuation and fundamentals in focus for US investors - AD HOC NEWS
CVS Can Keep Trial Win In Cooler Injury Case, 7th Circ. Says - Law360
Dollar Tree takes over closed CVS Pharmacy near Jacksonville University - Jacksonville Daily Record
Aetna Launches Aetna Mental Health on Demand To Provide Real Time Access to Care and Ongoing Support - ACCESS Newswire
Cantor Fitzgerald reiterates CVS Health stock Overweight rating - Investing.com
Patients Denied Care, Then Approved Later? Federal Watchdog Raises Medicare Advantage Concerns - Benzinga
Cantor Fitzgerald reiterates CVS Health stock Overweight rating By Investing.com - Investing.com Canada
CVS Faces Scrutiny Over Medicare Advantage Denials - GuruFocus
CVS Health Corporation $CVS Shares Sold by Townsquare Capital LLC - MarketBeat
Illinois Municipal Retirement Fund Purchases 62,717 Shares of CVS Health Corporation $CVS - MarketBeat
Deutsche Bank AG Acquires 1,031,998 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Sold by Cerity Partners LLC - MarketBeat
CVS Health (NYSE:CVS) Sets New 12-Month HighHere's What Happened - MarketBeat
Musab Balbale Departs CVS Health; Zach Dennett Named Interim Merchandising Leader - Yahoo! Finance Canada
CVS Health stock hits 52-week high at 98.44 USD - Investing.com India
CVS Health expands GLP-1 coverage, adds Zepbound to formulary - Investing.com
CVS Health expands GLP-1 coverage, adds Zepbound to formulary By Investing.com - Investing.com Canada
CVS Caremark Delivers Affordability and Access to GLP-1 Weight Management Medications With Expanded Coverage Options - marketscreener.com
CVS Health Corporation $CVS Shares Bought by Motley Fool Asset Management LLC - MarketBeat
Franklin Resources Inc. Sells 3,438,834 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Health Corporation $CVS Shares Purchased by Erste Asset Management GmbH - MarketBeat
Brandes Investment Partners LP Acquires 45,860 Shares of CVS Health Corporation $CVS - MarketBeat
CVS Offers A Compelling Turnaround Opportunity Not Seen In Years (NYSE:CVS) - Seeking Alpha
CVS Stock Quote Price and Forecast - CNN
Bullish on CVS Health Corp. - The Globe and Mail
CVS Health (CVS) Valuation Check As GLP 1 Access Expands And PBM Scrutiny Intensifies - Yahoo Finance
CVS Health Recognized for Technology That Improves Medication Safety and Patient Care - marketscreener.com
Aetna Better Health of Missouri, community orgs expand access to maternal care in rural communities - Drug Store News
O Shaughnessy Asset Management LLC Buys 32,536 Shares of CVS Health Corporation $CVS - MarketBeat
How CVS Generates Revenue: A Look at Their Business Model - Investopedia
Cvs Health Corp Stock (CVS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):